Q & A
Our Q&A interviews offer investors a chance to listen a conversation with C-Suite Executives of UK-listed companies.
In depth Q&A with Oncimmune CEO, Dr Adam M Hill
13th Nov 2020 12:03
See more in series
Login or register to post comments